580 likes | 948 Views
DEFINITION. Loss of three or more clinically recognized pregnancy losses before 20 wks gestation.Clinical investigation should however be initiated after 2 consecutive losses specially when fetal heart activity has been identified before any pregnancy losses, when the woman is >35 yr or when the c
E N D
1. RECURRENT MISCARRIAGECURRENT CONCEPTS SUSHANTA BHADRA
FEBRUARY 2004
WEXHAM PARK Distressing for the patient and frustrating for the physician
Cause is usually not apparent and often requires intensive and expensive clinical and laboratory investigations, despite which there is only limited understanding of the subjectDistressing for the patient and frustrating for the physician
Cause is usually not apparent and often requires intensive and expensive clinical and laboratory investigations, despite which there is only limited understanding of the subject
2. DEFINITION Loss of three or more clinically recognized pregnancy losses before 20 wks gestation.
Clinical investigation should however be initiated after 2 consecutive losses specially when fetal heart activity has been identified before any pregnancy losses, when the woman is >35 yr or when the couple has difficulty conceiving.
3. epidemiology Affects 0.5-3% of all women
Risk of subsequent loss - 24% after 2
30% after 3
40% after 4 Definitions not adhered to at all times
Some have included only first trimester losses, some only 2nd trim
Specify the type of loss- preclinical- demise before 6wks , embryonic loss 6-10wks fetal loss 10-20 wks
Important to understand different definitions before comparing dataDefinitions not adhered to at all times
Some have included only first trimester losses, some only 2nd trim
Specify the type of loss- preclinical- demise before 6wks , embryonic loss 6-10wks fetal loss 10-20 wks
Important to understand different definitions before comparing data
4. PROPOSED ETIOLOGIES Genetic - 5 %
Anatomic- 15%
Endocrine- 20%
Infections- 5%
Immunologic/ Thrombotic -30%
Other factors 10%
Unknown
5. Genetic mechanisms Chromosomal abnormalities
numerical aneuploidies
structural - translocations
Single gene ( Mendelian)
Polygenic ( single anatomic defect)
6. Chromosomal abnormalities Spontaneous abortions
Normal chromosomes 40-50%
Abnormal chromosomes- 50-60%
7. aneuploidies
Trisomies (extra chromosome) and
monosomies (missing chromosome)
Segregation errors during cell division
Sporadic
Nonrecurrent
Trisomies associated with maternal age
8. Abnormal chromosomes Autosomal trisomy 50%
Monosomy X 25%
Polyploidy 20%
Sex chromosome polysomy - rare
Translocations - < 5%
9. Autosomal trisomies Chromosomes
10% 13 5.8%
25% 14, 18 5%
3,5,6 ,11,12,17 - <1% 157.2%
4 , 20 2.5% 1631%
74.5% 21 8.4%
8,93.5% 22 ---11%
10. Parental origin - trisomy Maternal 9095% --
age related
recurrent
Paternal 510%
11. Aneuploid screening There is an increased rate of numerical chromosomal abnormalities in human periimplantation embryos in women with RSA
There is also an increased incidence of chromosomal abnormalities in the sperm from RSA couples
Role of preimplantation genetic diagnosis (day3 - blastomeres ) using FISH
12. Structural chromosomal abnormalities Defect in structure of 1 or more chromosomes
Inversions, translocations
7% couples affected
Risk of spontaneous abortions vary from 25-50%
May be passed from parent to child
Karyotype indicated When a parent carries a balanced chromosome rearrangement the chance of having a live birth with unbalanced chromosomal complement is usually about 1 -15%. The exact risk depends on the specific chromosomes involved , size of the segments involved , sex of the transmitting parent, family history and mode of ascertainment.When a parent carries a balanced chromosome rearrangement the chance of having a live birth with unbalanced chromosomal complement is usually about 1 -15%. The exact risk depends on the specific chromosomes involved , size of the segments involved , sex of the transmitting parent, family history and mode of ascertainment.
13. TRANSLOCATIONS Reciprocal --- any chromosome
Robertsonian (centric fusion)
only acrocentric chromosomes 13,14,15,21,22
Cryptic translocations - balanced translocations involving only the telomeric regions of the chromosomes not detectable by conventional cytogenetics In reciprocal translocation pieces from 2 non-homologous chromosomes have switched places with each other, in Robertsonian 2 acrocentric chromosomes are fused togetherIn reciprocal translocation pieces from 2 non-homologous chromosomes have switched places with each other, in Robertsonian 2 acrocentric chromosomes are fused together
14. Other chromosomal rearrangements Inversions
Balanced complex translocations
Interchromosomal insertions
Jumping chromosomes
15. X Chromosome inactivation Occurs in female mammals
Random inactivation of a X chromosome to compensate for the difference in x linked gene dosage
Preferential inactivation of x chromosome is directly correlated with RM
Underlying causes include cryptic x chromosome aberrations, gene microdeletions, gene mutations and genetic imprinting
16. Chromosomal causesConclusions Aneuploidies are responsible in 55-85% of EPL
Trisomies are usually maternal meiotic in origin and age related.
Polyploidy(67%) and Monosomy X(80%) are usually paternal in origin
Trisomies can be recurrent
Parental translocations found more often in female, not highly correlated with number of losses and show 2-5% unbalanced offspring
17. Single gene defects Maternal endometrial, immunologic, vascular
Embryonic developmental
Genes conferring pharmacologic susceptibility to toxins or infections
Genes causing aneuploidy
18. Polygenic 2 or more genes cumulatively affect presence or absence of a given trait
Unequivocal relationship to 2nd and 3rd trimester losses
Associated with anatomic defects involving single organ system
Associated with subsequent live born ntd and prior polygenic defects
Fetuses with anatomic defects (embryoscopy) usually show cytogenetic abnormalities
Recurrence risk 1-5% limited to first degree relatives
19. Maternal gene perturbations Mutant maternal gene likely to be associated with consecutive losses not interspersed as in genes acting through embryos
Endometrial receptivity (PR)
Luteal Function (CYP 17)
Alloimmune (HLA G promoter polymorphism)
20. Lethal genes affecting fetus Early lethal Surf 1 , ETA2 , OCT 4( mice models human analogies present neurodevelopmental problems )
Placental trophoblast differentiation , fetoplacental vascular development , trophoblast transcription factors
Homebox and other developmental : HOX PAX Lethal recessive genes usually produce non consecutive losses
If lethal dominant factors are resonsible for deleterios embryonic effect would cause repeted losses if parental gonadal mosaicism existsLethal recessive genes usually produce non consecutive losses
If lethal dominant factors are resonsible for deleterios embryonic effect would cause repeted losses if parental gonadal mosaicism exists
21. Hla genotypesThe REMIS Trial analysis of 12 HLA g alleles in prospectively followed cohorts of couples with recurrent miscarriages using PCR sequence specific oligonucleotides for 12 alleles
113 couples studied- 63 with successful pregnancy, 50 with rm
22. Remis trial HLA g gene genotype 0104 and 0105n is predictive of low successful pregnancy rates
Presence of HLA G isoform 1 and 725C/G polymorphism in promoter regions are associated with an increased risk of recurrent miscarriages if both partners carried the allele
23. The Paternal contribution Balanced structural chromosomal abnormalities
Sperm abnormalities
Sub chromosomal abnormalities
subtle chromosome rearrangements
gene dosage imbalances
Mutations Early studies using conventional semen analysisi showed that semen from male partners of women with rm were not significantly abnormal
Recent studies have shown higher aneuploidy rates
Paternal genome plays a role in early embryogenesis sperm chromatic structure assay(SCSA) meeasures chromatin susceptibility to acid denaturation. High scsa values are associated with rm
Increaased rates of miscarriages has been observed in icsi cyles in patients known to have meiotic disorders.Early studies using conventional semen analysisi showed that semen from male partners of women with rm were not significantly abnormal
Recent studies have shown higher aneuploidy rates
Paternal genome plays a role in early embryogenesis sperm chromatic structure assay(SCSA) meeasures chromatin susceptibility to acid denaturation. High scsa values are associated with rm
Increaased rates of miscarriages has been observed in icsi cyles in patients known to have meiotic disorders.
24. Sperm abnormalities 24 couples with rm semen analysis&Fish
Characteristic rec misc fertile donors
Motile 46% 49%
Tapered 38% 16%
Amorphous 9% 5%
Viable 56% 71%
(Carrell 2003)
25. Sperm abnormalities Disomy rec misc sperm donors
Xy 0.77% 0.31%
13 1.02% 0.39%
18 0.51% 0.25%
21 0.47% 0.28%
26. Sperm aneuploidy Mechanisms
Quality marker ?
Carrier of a defect that influences post zygotic aneuploidy , implantation, embryonic growth
27. The role of the trophoblast Placental development
Continuous turnover
CT proliferation differentiation fusion aging shedding as syncitial knots into maternal circulation over 3- 4 weeks
CT / ST ratio reduced in apl pregnancies and rsas
Tenney Parker changes
Dvillous trophoblast displays a continuous turnover from proliferation of cytotrophoblast cells to late apoptosis inside th syncytiotrophobblast leading to extrusion of syncitial knots in the maternal circulation
In 1st trimester ratio of number of ct and the no of nuclei absorbed in st could be predictive of placental survival and growth ct st ratio
During late pregnancy extrusion of syncitial material is achieved by a variety of methods tenney parker changes are syncitial knotting described as histological term to describe the histological appearance of increased numbers of seemingly multinucleated trophoblastic outgrowths at the villous surface. - widely accepted as diagnostic marers of placental ischemia and pet
Patterns of shedding -- arrested shedding IUGR
Necrotic shedding in PETDvillous trophoblast displays a continuous turnover from proliferation of cytotrophoblast cells to late apoptosis inside th syncytiotrophobblast leading to extrusion of syncitial knots in the maternal circulation
In 1st trimester ratio of number of ct and the no of nuclei absorbed in st could be predictive of placental survival and growth ct st ratio
During late pregnancy extrusion of syncitial material is achieved by a variety of methods tenney parker changes are syncitial knotting described as histological term to describe the histological appearance of increased numbers of seemingly multinucleated trophoblastic outgrowths at the villous surface. - widely accepted as diagnostic marers of placental ischemia and pet
Patterns of shedding -- arrested shedding IUGR
Necrotic shedding in PET
28. Placental oxidative stress Human fetus develops in a low oxygen environment
Intraplacental oxygen conc increases from < 20mm Hg at 10 wks to > 50 at 12 wks
Trophoblastic cells are extremely sensitive to oxidative stress
Mounting evidence that in most miscarriages the onset of intervillous circulation is premature and widespread due to incomplete transformation of uteroplacental arteries leading to high oxygen concentrations in early pregnancy
29. Placental oxidative stress
30. Endometrial receptivity INFERTILITY RM
50-75% of pregnancies lost represent a failure of implantation
Failure of implantation may result from a non receptive endometrium
Involves a complex synchronous interaction between embryo , endometrium and ovary IM PLANTATION REQUIRES INTERACTION BETWEEN EMBRYO AND ENDOMETRIUM. DESCRIBED IN 50S BASED ON ANIMAL STUDIES IM PLANTATION REQUIRES INTERACTION BETWEEN EMBRYO AND ENDOMETRIUM. DESCRIBED IN 50S BASED ON ANIMAL STUDIES
31. Endometrial receptivity Growth factors LIF,HB EGF
Cytokines
Adhesion molecules- integrins A5, B3
Steriod hormones and receptors
Immunologic factors-- NK Cells, T cells
Prostaglandins LIF leukemia inhibiting factor hBEGF - heparin binding epidermal growth factor
LIF PRESENT IN ENDOMETRIUM AT TIME OF IMPLANTATION ( d20-24), DECREASED LIF ASSOCIATED WITH RM
Decreased lif is associated with rm antiprogesterones decrease lif expression. Hbgef increased by est and prog, stimulates embryo development and trophoblast growth steroid hormones regulates proliferation and diff of endometrial stromal celss , regulates expression of hox genes, stimulates embryo adhesionLIF leukemia inhibiting factor hBEGF - heparin binding epidermal growth factor
LIF PRESENT IN ENDOMETRIUM AT TIME OF IMPLANTATION ( d20-24), DECREASED LIF ASSOCIATED WITH RM
Decreased lif is associated with rm antiprogesterones decrease lif expression. Hbgef increased by est and prog, stimulates embryo development and trophoblast growth steroid hormones regulates proliferation and diff of endometrial stromal celss , regulates expression of hox genes, stimulates embryo adhesion
32. RX to improve endometrial receptivity Progesteroneat best controversial , at worst ineffective
Immunomodulation
paternal cell immunization
intravenous immunoglobulin PROGESTERONE AND IMMUNOSUPPRESSION STIMULATES GROWTH FACTORS, HOXA GENE EXPRESSION AND ADHESION MOLECULES
INHIBITS LYMPHOCYTE CYTOTOXICITY, PROINFLAMMATORY CYOTKINES , NK CELL DEGRANULATION AND CYTOKINE PRODUCTIONPROGESTERONE AND IMMUNOSUPPRESSION STIMULATES GROWTH FACTORS, HOXA GENE EXPRESSION AND ADHESION MOLECULES
INHIBITS LYMPHOCYTE CYTOTOXICITY, PROINFLAMMATORY CYOTKINES , NK CELL DEGRANULATION AND CYTOKINE PRODUCTION
33. Novel Therapies Intrauterine Prostaglandins
Intrauterine steroids
Intrauterine Peripheral blood mononuclear cells
L arginine
Glue Fibrin!
34. Infections 1 in 20 women are exposed to pathogens
Majority are harmless
Early infection congenital problems
Delayed infection -
35. Infections - spectrum MISCARRIAGES
CONGENITAL INFECTIONS
STILL BIRTH
NEONATAL DEATHS
ASYMPTOMATIC INFECTIONS
NORMAL FINDINGS
36. INFECTIONS Rubella
CMV
HBV
VZ
HSV
HIV
GBS
Syph
37. Infections What do they do ? Direct effect on ova
Endometrial infection implantation defects
Embryopathy
Placental infections
Amniotic fluid infection
38. UTERINE PATHOLOGY Septate uterus-
Ashermans Syndrome-
Uterine Fibroids- esp. sub mucous
Primary endometrial defects
Des exposure
Septate uterus is most common and there is impairment of implantation due to avascularity- also reduced sensitivity to steroids
Ashermans- reduced rewponsiveness to steroids- extensive dense fibrosis carries a poor prognosis
Fibroids observational data from six ivf series modestly compromised with intramural,possibly with sebserous
Removal of submucous fibroids reduces miscarriage rates- possibly also with intramural
Hsgs in rm- normal- 43 septum 22 ashermans- 23 polyps -1
Conflicting results on relationships between ER and PR receptors and RM- links to renewed interest after discovery of Era and PRB receptore no reltionship to AR receptorsSeptate uterus is most common and there is impairment of implantation due to avascularity- also reduced sensitivity to steroids
Ashermans- reduced rewponsiveness to steroids- extensive dense fibrosis carries a poor prognosis
Fibroids observational data from six ivf series modestly compromised with intramural,possibly with sebserous
Removal of submucous fibroids reduces miscarriage rates- possibly also with intramural
Hsgs in rm- normal- 43 septum 22 ashermans- 23 polyps -1
Conflicting results on relationships between ER and PR receptors and RM- links to renewed interest after discovery of Era and PRB receptore no reltionship to AR receptors
39. Cervical Cerclage Shirodhkar
McDonalds
Lash
Benson Durfee
40. Indication for abd cerclage Congenital short cx
Amputated cx
Torn cx
Severe scarring
Chronic cervicitis
Cervicovaginal fistula
Failed shirodhkar
Rec pproms
Cervical dysfunction
41. Cervical cerclage Steer Modifications
Nuchal first
USS guidance before , during and after
No bladder dissection
Straight blunt needle
42. PROTHROMBOTIC STATES Antiphospholipid syndromes
Heritable Thrombophilia-antithrombin def
protein C & S def
Factor V Leiden
Prothrombin20210 A
Thrombocythemia
43. ANTIPHOSPHOLIPID SYNDROME 7-42 % OF WOMEN
Wide variation
Poor laboratory standardization
44. APL diagnostic criteria 3 or more unexplained consecutive spontaneous abortions before 10 wks with exclusion of maternal anatomic or hormonal abnormalities and maternal and paternal chromosomal abnormalities
OR
One or more unexplained deaths of a morphologically normal fetus at or beyond 10 wks with normal fetal morphology documented by USS or direct examination of the fetus
OR
One or more PTBs of a morphologically normal neonate at or before 34wks gest because of severe PET or Placental Insufficiency
45. AND Persistent abnormality of the following tests when measured twice at least 6 wks apart
Lupus anticoagulant
Antiphospholipid antibodies IgG or IgM
46. Pathophysiology of APS Thrombotic
Lack of Trophoblastic invasion in 1st trimester decidua
47. APL Maternal Risks Thrombosis Heparin RX
Access to prenatal care and pt education
Hypertension antenatal care and pt education
Thrombocytopenia
Secondary conditions rheumatologist involvement
Treatment Complications hge, osteopenia, thrombocytopenia
Catastrophic APS
48. FETAL RISKS Miscarriage
Uteroplacental insufficiency
IUD
IUGR
Fetal Distress
Preterm birth
SLE and Thrombosis
49. Heritable thrombophilias 5 recognized defects antithrombin def, protein c def, protein s def, v leiden, prothrombin 20210A variant
EPCOT European study analysed pregnancy outcome in women with known thrombophilia v leiden not associated with rm, better association with activated protein c resistance
Essential thrombocythemia
50. ENDOCRINOLOGICAL FACTORS Hypersecretion of LH(>10IU/L)In the follicular phase is a marker for RM
Androgen levels in the follicular phase have been shown to be high in pts with RM- This correlates negatively with the conc. of Placental Protein 14 a biochemical marker for endometrial function
Hyperprolactinemia no firm evidence Difficult to evalauate role of LH for different assay methods,sifferent samples, different timings pulsatile release of LH- hypersecretion mainly in urine samples- may be an overestimate as suppression of LH does not have an observable beneficial effect occurs in only 8% of women
PCO not predictive of pregnancy loss- Rai 2000 prevalance of PCO in rm is 40% - live birth rate similar in pco(60%) to normal women (59%)Difficult to evalauate role of LH for different assay methods,sifferent samples, different timings pulsatile release of LH- hypersecretion mainly in urine samples- may be an overestimate as suppression of LH does not have an observable beneficial effect occurs in only 8% of women
PCO not predictive of pregnancy loss- Rai 2000 prevalance of PCO in rm is 40% - live birth rate similar in pco(60%) to normal women (59%)
51. IMMUNOLOGICAL FACTORS
Autoantibodies 18-43% of pts with RM
APL --14%
ANA 7%
Antisperm AB
Thyroid Peroxidase
31 % of patients of rm have positive test results with one or both thyroid ab- peroxidase and thyroglobulin-may be aresult direct effect of autoab on fetal tissue or representing a more generalized defect in auto immunity
Peroxidase ab has prognostic value- titre declines with positive outcome of pregnancy31 % of patients of rm have positive test results with one or both thyroid ab- peroxidase and thyroglobulin-may be aresult direct effect of autoab on fetal tissue or representing a more generalized defect in auto immunity
Peroxidase ab has prognostic value- titre declines with positive outcome of pregnancy
52. Immunology Alterations in Cellular Immune Function
NK cells-
LGL cells CD56+ increased in endometrium of RM pts Around time of implantation 20% cells of endometrial stroma are leucocytes majority being of large granular types with surface markers for cd56,cd16 and cd3 like nk celss- staining for cd56,4,14,16, and mhc class2 are increased in rm( data from endometrial biopsies0Around time of implantation 20% cells of endometrial stroma are leucocytes majority being of large granular types with surface markers for cd56,cd16 and cd3 like nk celss- staining for cd56,4,14,16, and mhc class2 are increased in rm( data from endometrial biopsies0
53. OTHER FACTORS COFFEE
SMOKING AND ALSCOHOL
HYPERHOMOCYSTENEMIA- Interferes with embryonic development
SELENIUM DEFICIENCY
CELIAC DS
STRESS
PCP EXPOSURE
MATERNAL DS Hyperhomocysteinemia associated with arterial and venous thrombosis- levels fall in pregnancy- high levels are associated with pregnancy complications including ntds , placental infardcts, iugr, placental abruption
Meta analysis of dat\a shows significvant correlation between hyperhomocystenemia and rm
Folate deficiency is the commonest acquired causes genetic causes \mthfr gene defect( polymorphism at position 677 of gene ) causes a thermolabile variant- take fasting blood process within 1 hr
Stress may be linked to immunological imbalancesHyperhomocysteinemia associated with arterial and venous thrombosis- levels fall in pregnancy- high levels are associated with pregnancy complications including ntds , placental infardcts, iugr, placental abruption
Meta analysis of dat\a shows significvant correlation between hyperhomocystenemia and rm
Folate deficiency is the commonest acquired causes genetic causes \mthfr gene defect( polymorphism at position 677 of gene ) causes a thermolabile variant- take fasting blood process within 1 hr
Stress may be linked to immunological imbalances
54. BASELINE INVESTIGATIONS ENDOCRINELH,FSH,TSH,PRL,PRG
BIOCHEMICAL BLOOD SUGAR , HOMOCYSTEINE
UTERINE USS, HSG
IMMUNOLOGICAL LUPUS,APL,C3,4
THROMBOPHILIA SCREEN
GENETIC
55. PROGNOSTIC FACTORS Fetal Heart Beats
No of prev misc
Age
Underlying etiology
History of live birth
Underlying infertility
BMI
Menstrual cycles
In a low risk population risk of miscarriage is 2-6% once fhr is seen. In high risk populations this ranges from10-30% esp in older women , so do not put undue stress on this
Live birth rate falls from 65% in women with 2 misc to 43% in women with 6 miscarriages
Higher fetal loss in older women
Bmi not related to misc
Regular cycles positively correted with live birthrateIn a low risk population risk of miscarriage is 2-6% once fhr is seen. In high risk populations this ranges from10-30% esp in older women , so do not put undue stress on this
Live birth rate falls from 65% in women with 2 misc to 43% in women with 6 miscarriages
Higher fetal loss in older women
Bmi not related to misc
Regular cycles positively correted with live birthrate
56. Neonatal Outcome Increased Risk of
SFD
PTL
PNM
LSCS Reginald -97 women in 87- small for gest age in 30%,preterm del in 28%.mortlqaity in 2% -no controls and underlying cause and treatment not documented . Hughes (91) compared to a control gr and found small for gest age in 3.4%, preterm del in 12% and perinatal mortality in 0- no different from control gr.- again incomplete data re diagnosisand treatment
Recently Jivraj())!)- in cohort of women with rm compared to controls preterm del 14%,small for dates 13%,pperinatal mortality 2.5% , lscs 40%- higher than in controlReginald -97 women in 87- small for gest age in 30%,preterm del in 28%.mortlqaity in 2% -no controls and underlying cause and treatment not documented . Hughes (91) compared to a control gr and found small for gest age in 3.4%, preterm del in 12% and perinatal mortality in 0- no different from control gr.- again incomplete data re diagnosisand treatment
Recently Jivraj())!)- in cohort of women with rm compared to controls preterm del 14%,small for dates 13%,pperinatal mortality 2.5% , lscs 40%- higher than in control
57. MANAGEMENT CAUSE SPECIFIC
Uterine anomalies metroplasty, hysteroscopic surgery
Endometrial defect- prime endometrium in follicular phase with estrogen, GnRH
Prothrombotic states- aspirin, heparin, steroids
PCOS laparoscopic drilling associated with reduced miscarriage rate
Aspirin and heparin together results in a successful outcome in 70% cases start aspirin at positive pregnancy test and heparin at detection of fhr stop at 34 wks- monitor platelets weekly for 4 wks and 3 wks thereafter- postnatal prophylaxis not reqiured for rmAspirin and heparin together results in a successful outcome in 70% cases start aspirin at positive pregnancy test and heparin at detection of fhr stop at 34 wks- monitor platelets weekly for 4 wks and 3 wks thereafter- postnatal prophylaxis not reqiured for rm
58. MANAGEMENT TLC including serial uss
Progestogens- no clear benefit
Hcg- no evidence of benefit
Immunotherapy- Unproven
Aspirin empirical use not justified
Thyroid hormones
Folic acid
Immunotherapy active and passive paternal leucocyte immunizaation, trophoblast membrane infusion, iv immunoglobulinsImmunotherapy active and passive paternal leucocyte immunizaation, trophoblast membrane infusion, iv immunoglobulins
59. THANK YOU